Laurus Labs Limited vs Shukra Pharmaceuticals Ltd
A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Shukra Pharmaceuticals Ltd (SHUKRAPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Shukra Pharmaceuticals Ltd leads LAURUSLABS vs SHUKRAPHARMACEUTICALSLTD on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth11
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SHUKRAPHARMACEUTICALSLTD takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LAURUSLABS takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
- + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has delivered good profit growth of 175% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%"]
- − ["Stock is trading at 19.0 times its book value", "Debtor days have increased from 122 to 148 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.